
CTI, Humanigen Inc. dose first COVID-19 patient with FDA-approved lenzilumab proprietary antibody
Covington’s CTI partner, Humanigen Inc., has announced that the first COVID-19 patient has been dosed with its FDA-approved proprietary antibody…
Covington’s CTI partner, Humanigen Inc., has announced that the first COVID-19 patient has been dosed with its FDA-approved proprietary antibody…
Covington-based CTI Clinical Trial and Consulting Services has partnered with California-based Humanigen, Inc. on a study for the treatment of novel…